Literature DB >> 8663327

Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes.

M Yin1, S Q Yang, H Z Lin, M D Lane, S Chatterjee, A M Diehl.   

Abstract

Hepatocytes were cultured in the presence of recombinant tumor necrosis factor (TNF) alpha or mutated TNF alpha peptides that specifically activate either p55 or p75 TNF receptors to determine if TNF alpha can activate cytokine-inducible CCAAT/enhancer binding protein (C/EBP) isoforms by post-transcriptional mechanisms that are initiated by TNF receptors. Within 5-10 min after treatment with any of these agents, nuclear concentrations of C/EBP beta and C/EBP delta double and remain 2-4-fold greater than control cultures for 30 min (p < 0.01). Consistent with these results, gel mobility shift assays demonstrate 3-fold increased nuclear C/EBP beta- and C/EBP delta-DNA binding activity in TNF alpha-treated cells, and immunocytochemistry confirms rapid redistribution of these C/EBP isoforms into the nucleus. In contrast, mRNA and whole cell protein concentrations of C/EBP beta and delta are not altered by TNF alpha exposure, and nuclear concentrations of another C/EBP isoform, C/EBP alpha, are decreased by 80%. This novel evidence that TNF alpha initiates post-transcriptional activation of cytokine-inducible C/EBP isoforms identifies a mechanism that enables hepatocytes to respond immediately to inflammatory stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663327     DOI: 10.1074/jbc.271.30.17974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  C/EBP alpha and C/EBP beta regulate haptoglobin gene expression during rat liver development and the acute-phase response.

Authors:  Svetlana Dinić; Desanka Bogojević; Miodrag Petrović; Goran Poznanović; Svetlana Ivanovic-Matić; Mirjana Mihailović
Journal:  Mol Biol Rep       Date:  2005-09       Impact factor: 2.316

3.  A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors.

Authors:  J G Jiang; R Zarnegar
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Nuclear factor κB up-regulation of CCAAT/enhancer-binding protein β mediates hepatocyte resistance to tumor necrosis factor α toxicity.

Authors:  Yongjun Wang; Rajat Singh; Youqing Xiang; Linda E Greenbaum; Mark J Czaja
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

5.  CREB controls LAP/C/EBP beta transcription.

Authors:  M Niehof; M P Manns; C Trautwein
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Concanavalin A-induced liver injury triggers hepatocyte proliferation.

Authors:  C Trautwein; T Rakemann; N P Malek; J Plümpe; G Tiegs; M P Manns
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 7.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

8.  Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha.

Authors:  M Buck; L Zhang; N A Halasz; T Hunter; M Chojkier
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

9.  C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages.

Authors:  Michelle N Bradley; Liang Zhou; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Nucleolar retention of a translational C/EBPalpha isoform stimulates rDNA transcription and cell size.

Authors:  Christine Müller; Anna Bremer; Sandra Schreiber; Sabrina Eichwald; Cornelis F Calkhoven
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.